OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Interest Income

Income earned on cash, deposits, and investments held by the company.

OrganiGram Holdings Inc.TSX: OGI.TO

Interest Income · Q2 FY2026 · quarter ended Mar 2026

Interest income growth accelerates

Q2 FY2026 interest income of CA$312K rose 74.3% year over year, ahead of the -74.5% change in trailing-twelve-month interest income.

Context

  • Interest income amounted to 0.4% of revenue in FY2025, down 1.6 pp from a year earlier.
  • Interest income increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +74.3% holds above the trailing-twelve-month pace of -74.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$312K— QoQ
Last fiscal yearSep 2025
CA$1.15M-65.3% YoY
LTMMar 2026
CA$458K-74.5% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+74.3%——
1 year-65.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Income history

CAD · from the income statement

Latest · FY2025
1.15M CAD
Year-over-year change
-65.3%

Interest Income vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -74.5% is the 8th highest of 9, against a peer median of -45.0%.
  • Interest income amounts to 0.2% of revenue for OGI.TO, versus a peer median of 0.4%.
OGI.TO Competitors
Interest Income for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$10.78M CAD+22.3%-25.6%3.5%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$6.6M CAD-42.6%-32.5%2.1%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$2.1M USD+137.0%+36.2%—
DR.TOMedical Facilities CorporationLTM Mar 2026$1.84M USD-32.7%-36.0%0.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$892.63K USD-47.4%+60.1%1.7%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$458K CAD-74.5%—0.2%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$141K CAD-47.4%-27.2%0.1%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$87.08K USD-59.3%+24.1%0.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%—0.0%
TSND.TOTerrAscend Corp.LTM Mar 2026$0 USD——0.0%
Peer median (excluding OGI.TO) —-45.0%-25.6%0.4%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M259.18M
Cost of Revenue107.56M114.24M114.13M112.32M249.67M
Gross Profit(28.4M)31.57M35.07M47.52M9.51M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.52M59.21M71.68M68.14M86.88M
Operating Expenses63.42M70.32M277.81M83.2M97.82M
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
EBITDA(95.59M)10.97M(207.62M)(23.59M)(20.55M)
EBITDA Margin-120.8%7.5%-139.2%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(88.31M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M3.31M1.15M
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M9.74M(9.77M)49.78M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(38.53M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)(5.28M)(13.77M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.19)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.19)
Weighted Avg Shares64.03M77.23M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M77.23M81.29M95.29M127.67M

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.